Skip to main content
Lipocine Inc. (LPCN)
NASDAQ: LPCN · IEX Real-Time Price · USD
6.92
-0.01 (-0.14%)
At close: May 31, 2024, 4:00 PM
7.05
+0.13 (1.88%)
After-hours: May 31, 2024, 7:32 PM EDT

Lipocine Revenue

Lipocine had revenue of $4.71M in the twelve months ending March 31, 2024, with 748.91% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $7.62M with 13,751.93% year-over-year growth. In the year 2023, Lipocine had annual revenue of $-2.85M, a decrease of -670.16%.

Revenue (ttm)
$4.71M
Revenue Growth
+748.91%
P/S Ratio
7.85
Revenue / Employee
$277,139
Employees
17
Market Cap
37.01M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023-2.85M-3.35M-670.16%
Dec 31, 2022500.00K-15.64M-96.90%
Dec 31, 202116.14M--
Dec 31, 20200--
Dec 31, 2019164.99K-263.04K-61.45%
Dec 31, 2018428.03K--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Dec 31, 20127.71M--
Dec 31, 20110--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
The Oncology Institute 342.71M
Fortress Biotech 85.11M
iCAD, Inc. 19.63M
electroCore 18.69M
Evogene 9.19M
Cyclo Therapeutics 1.13M
VYNE Therapeutics 423.00K
Revenue Rankings

LPCN News

More News